<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[16, 28] patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud<br>[135, 139] Ninety-three subjects<br></td>
<td width=33%>
[16, 34] patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud study (KOARA study).<br>[135, 143] Ninety-three subjects were randomly assigned.<br></td>
<td width=33%>
[16, 35] patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud study (KOARA study).

<br>[77, 86] nifedipine SR group (Group N) or the<br>[88, 94] extract group (Group G)<br>[135, 143] Ninety-three subjects were randomly assigned.<br>[205, 208] Korean patients.<br>[215, 217] patients.<br></td>
</tr>
